Loading...

Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via cAMP/PKA/CREB‐FtMt signalling axis

OBJECTIVE: We previously demonstrated the roflumilast inhibited cell proliferation and increased cell apoptosis in ovarian cancer. In this study, we aimed to investigate the roles of roflumilast in development of cisplatin (DDP)‐sensitive and ‐resistant ovarian cancer. METHODS: OVCAR3 and SKOV3 were...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cell Prolif
Main Authors: Gong, Shipeng, Chen, Yongning, Meng, Fanliang, Zhang, Yadi, Li, Chanyuan, Zhang, Guangping, Huan, Wu, Wu, Fei
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528923/
https://ncbi.nlm.nih.gov/pubmed/30069985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12474
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!